Quetiapine versus sertraline as the pharmacological component in a standardised psychopharmacological and psychotherapeutic treatment of borderline personality disorder: a randomised, rater-blinded study

Trial Profile

Quetiapine versus sertraline as the pharmacological component in a standardised psychopharmacological and psychotherapeutic treatment of borderline personality disorder: a randomised, rater-blinded study

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2009

At a glance

  • Drugs Quetiapine; Sertraline
  • Indications Borderline personality disorders
  • Focus Therapeutic Use
  • Acronyms QuBor
  • Most Recent Events

    • 15 Mar 2009 Status changed from active, no longer recruiting to completed, according to ISRCTN: Current Controlled Trials.
    • 23 Oct 2006 Status change
    • 22 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top